Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Mortality risk higher among children with primary immunodeficiency diseases infected with SARS-CoV-2

Children with certain immunodeficiency diseases carry mutations in genes that regulate the body's immune system against viral infections and they have a higher mortality rate due to COVID-19.

16 Sep 2022

University of Arkansas receives NIST award to improve palm-sized, low-cost and wireless COVID sensor

The National Institute of Standards and Technology, via an application from the RAPID Manufacturing Institute, awarded the University of Arkansas $699,604 to improve a Wi-Fi nano-biosensor that will be used in a palm-sized, low-cost and wireless SARS-COV-II detection system.

16 Sep 2022

Genomic sequencing reveals the course of COVID-19 in Africa

A new study explores the contribution of genomic sequencing to the scientific understanding of COVID-19, and on the introduction of global public health measures via the ability to pick up new variants early enough.

16 Sep 2022

SARS-CoV-2 N escape mutations do not affect rapid antigen testing

A new study maps the escape mutations found in various strains of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could cause them to escape neutralization by antibodies or detection by rapid antigen tests that rely on antibody binding for a positive result.

16 Sep 2022

SARS-CoV-2 infection and vaccination results in highest and longest-lasting antibody response

A prospective seroprevalence study in the Catalan population underlines the need to get vaccinated despite having been infected and confirms that hybrid immunity (vaccination plus infection) is more robust and long-lasting.

16 Sep 2022

One year later, 40% of patients with COVID pneumonia still had lung problems

A recent study published in the journal Respiratory Research found impaired lung function and dyspnea amongst severe COVID-19 pneumonia survivors one year post-infection. Meanwhile, many COVID-19 patients developed fibrotic-like sequelae as an aftermath of the infection-associated mild or severe pneumonia.

15 Sep 2022

KHN’s ‘What the Health?’: Graham’s bill recenters abortion debate

Sen. Lindsey Graham (R-S.C.) put abortion back on Republicans' agenda this week with a legislative proposal calling for a national ban on most abortions after 15 weeks of pregnancy.

15 Sep 2022

Study explores new-onset tinnitus after COVID-19 vaccination

In a new study, researchers assessed the incidence of new-onset tinnitus after coronavirus disease 2019 (COVID-19) vaccination.

15 Sep 2022

Survey highlights increase in the public's knowledge about monkeypox

The public's knowledge about monkeypox has increased rapidly in recent weeks though misconceptions and uncertainty persist, and over a quarter of Americans say they are not likely to get vaccinated against monkeypox if they're exposed to it, according to a new Annenberg Public Policy Center (APPC) survey.

15 Sep 2022

COVID-19 vaccine safety concerns result in lower vaccination rates among pregnant individuals in the United States

In a new study, researchers evaluated the factors associated with lower coronavirus disease 2019 (COVID-19) vaccination rates among pregnant individuals in the United States (U.S.).

15 Sep 2022

Study reveals pan-antiviral properties of PDC-109 bovine seminal plasma protein

In a new study, researchers explored the antiviral activity of the bovine seminal plasma protein PDC-109 against various mammalian viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Sep 2022

What is the COVID-19 prevalence among neonates?

A new study evaluated the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in newborns.

15 Sep 2022

Development of improved monoclonal antibodies against SARS-CoV-2

In a new study, researchers explored strategies for the development of effective monoclonal antibodies (mAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Sep 2022

Bivalent recombinant vaccine protects against SARS-CoV-2 and influenza in animal models

In a new study, researchers developed a recombinant bivalent vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza viruses.

15 Sep 2022

What is the effect of the Omicron variant on olfaction?

A new study discusses the effect of the Omicron variant of the virus on the olfactory system in humans.

15 Sep 2022

COVID-19's future is uncertain as infections increase and tracking decreases

Researchers review how the SARS-CoV-2 genome has changed throughout the COVID-19 pandemic.

14 Sep 2022

Mechanism of action of different COVID-19 vaccines

In a recent study posted to the bioRxiv* preprint server, researchers at the University of Tuebingen and Imperial College London assessed humoral and cellular immune responses elicited by the recombinant adenoviral vector (rAdVV)- and messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 (COVID-19) vaccines.

14 Sep 2022

Research shows a complex relationship between vaping and SARS-CoV-2 infection

In a recent study posted to the bioRxiv* pre-print server, researchers at the University of California, Riverside investigated the effects of electronic cigarette (EC) use as a risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

14 Sep 2022

Defensosomes versus COVID-19

In a recent study published in the journal PLoS Biology, researchers investigated the role of angiotensin-converting enzyme 2 (ACE2)-containing defensive exosomes, or 'defensosomes' against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

14 Sep 2022

High levels of mucosal antibodies in the airways reduce the risk of omicron infection

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three doses of the SARS-CoV-2 vaccine.

14 Sep 2022